IOVA icon

Iovance Biotherapeutics
IOVA

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.67
75% upside
High target

3 analyst ratings

positive
1  neutral
33%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
David Dai
5 Mar ‘26 1 month ago
Citizens
Citizens
Reni Benjamin
100% 1-yr IOVA win rate
3 Mar ‘26 1 month ago
Barclays
Barclays
Etzer Darout
100% 1-yr IOVA win rate
25 Feb ‘26 1 month ago